OC.08.4 RISK FACTORS FOR VIRAL REACTIVATION IN PATIENTS WITH OVERT OR OCCULT HEPATITIS B VIRUS INFECTION RECEIVING IMMUNOSUPPRESSIVE TREATMENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS. (March 2023)